Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Identifying the cheapest index funds for IRAs involves weighing costs against expected returns and risk. Learn practical benchmarking steps here.
22,746 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Imagine earning a slice of ownership just by staking crypto. Backpack aims to turn token holders into owners, but the...
A sweeping shift in capital gains rules could touch every investor. This guide breaks down what changes mean, who’s a...
Alphabet's stock has shown resilience amid AI-driven momentum and cloud growth. This guide breaks down whether google...
PI token rockets after a major exchange adds trading, even as Bitcoin stalls below $70,000. Analysts say new liquidit...
This in-depth look breaks down SAIC's saic (saic) 2026 earnings landscape, weighing revenue drivers, margins, and ris...
Fortune Brands Innovations stunned investors with a leadership overhaul after a zero-day CEO exit yielded $18.4 milli...
Policy makers and tech leaders converge to treat China as a shared risk in AI leadership, signaling potential shifts ...
A clear read of SERA’s Q1 2026 numbers and management commentary can shift an investor’s view of 2026. This guide bre...
A quiet-upstart tech company just got upgraded by analysts after solid earnings. This under-the-radar growth stock ma...
A small AI stock makes a big move. SoundHound AI just released a pivotal update that could affect its 2027 outlook an...
A civil suit over a $100 million claim has escalated into a courtroom confrontation between Galaxy Digital founder Mi...